|
MRPS16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.460000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.192190E-01 |
| Normal-vs-Stage2 |
1.033040E-01 |
| Normal-vs-Stage3 |
3.090800E-01 |
| Normal-vs-Stage4 |
1.005700E-02 |
| Stage1-vs-Stage2 |
4.643700E-03 |
| Stage1-vs-Stage3 |
5.736400E-01 |
| Stage1-vs-Stage4 |
9.900400E-02 |
| Stage2-vs-Stage3 |
1.603990E-02 |
| Stage2-vs-Stage4 |
6.232200E-04 |
| Stage3-vs-Stage4 |
6.470500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.524570E-01 |
| Normal-vs-AfricanAmerican |
5.035400E-01 |
| Normal-vs-Asian |
2.781600E-02 |
| Caucasian-vs-AfricanAmerican |
6.118800E-01 |
| Caucasian-vs-Asian |
2.628000E-01 |
| AfricanAmerican-vs-Asian |
2.322800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.116200E-02 |
| Normal-vs-Female |
4.745400E-01 |
| Male-vs-Female |
2.388200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.148400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.230400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.100800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.142400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.091200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.022500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.395400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.317700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.366800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.135400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.878400E-01 |
| Classical-VS-Follicular |
9.542500E-03 |
| Classical-VS-Other |
1.248560E-01 |
| Classical-VS-Normal |
9.525600E-02 |
| Tall-VS-Follicular |
2.676400E-02 |
| Tall-VS-Other |
4.699500E-02 |
| Tall-VS-Normal |
1.475050E-01 |
| Follicular-VS-Other |
6.327700E-02 |
| Follicular-VS-Normal |
3.589400E-01 |
| Other-VS-Normal |
2.092300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.081600E-01 |
| Normal-vs-N1 |
2.363500E-04 |
| N0-vs-N1 |
1.249460E-04 |
|
|
